Hopeful Lipid-Busters to Watch at AHA: New GLP-1, Gene Therapy, Oral PCSK9 Inhibitor

(MedPage Today) — NEW ORLEANS — Innovations in lipid lowering get a major chance to shine, and potentially move the needle in cardiometabolic treatment, this weekend here at the American Heart Association (AHA) annual meeting.
Spearheading…

Source link : https://www.medpagetoday.com/meetingcoverage/aha/118368

Author :

Publish date : 2025-11-07 16:22:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Hopeful Lipid-Busters to Watch at AHA: New GLP-1, Gene Therapy, Oral PCSK9 Inhibitor

A distant galaxy is being strangled by the cosmic web

Smoldering Myeloma Gets First FDA-Approved Therapy

Related Posts

What Did Trump’s MRI Assess?

For People With Seizures, It May Be Better to Be Old

Neflamapimod Shows Promise in Dementia With Lewy Bodies

Tai Chi for Insomnia; WHO Guidance on GLP-1 Drugs

The Other Screen Time Risk We Rarely Hear About

Nerve Stimulation for Epilepsy: Intracranial Versus Extracranial Approaches Compared

What Did Trump’s MRI Assess?

For People With Seizures, It May Be Better to Be Old

Neflamapimod Shows Promise in Dementia With Lewy Bodies

Tai Chi for Insomnia; WHO Guidance on GLP-1 Drugs

The Other Screen Time Risk We Rarely Hear About

Nerve Stimulation for Epilepsy: Intracranial Versus Extracranial Approaches Compared

Gene Therapy Also Effective in Younger Children With Inherited Blood Disorders

How Going Plant-based Could Prolong the Health Span

Categories

Archives